Does PALBOCICLIB Cause Intestinal obstruction? 135 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Intestinal obstruction have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
135
Reports of Intestinal obstruction with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
16
Deaths
95
Hospitalizations
How Dangerous Is Intestinal obstruction From PALBOCICLIB?
Of the 135 reports, 16 (11.9%) resulted in death, 95 (70.4%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which PALBOCICLIB Alternatives Have Lower Intestinal obstruction Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID